摘要 |
The invention relates to compounds of the formula I: wherein one of R<SUP>5</SUP>, R<SUP>6 </SUP>and R<SUP>7 </SUP>is and X<SUP>1</SUP>, X<SUP>2</SUP>, R<SUP>1 </SUP>to R<SUP>15 </SUP>and n are as defined in the description, and pharmaceutically acceptable salts and/or esters thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPAR delta and/or PPARalpha agonists. |